IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network (IPN)

Medicines For Uteri Cancer Treatment

IPN, New Delhi can facilitate Uteri cancer patient to “import of  Medicines For Uteri Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Uteri Cancer Treatment

Uterine cancer, also known as endometrial cancer, is a cancer that starts in the lining of the uterus. The most common type of uterine cancer is endometrial adenocarcinoma. Treatment for uterine cancer may involve surgery, radiation therapy, chemotherapy, and hormone therapy.

Get Access FDA Approved Medicines For Uteri Cancer Treatment

Surgery is usually the main treatment for uterine cancer and may involve a hysterectomy (removal of the uterus) and removal of the ovaries and fallopian tubes. In some cases, lymph nodes in the pelvis may also be removed.

Chemotherapy medications are commonly used for uterine cancer treatment. The specific chemotherapy drugs used may depend on the stage and type of uterine cancer, as well as the individual patient’s health status and other factors. Some common chemotherapy medications used for uterine cancer treatment include:

  • Paclitaxel (Taxol): Paclitaxel is a chemotherapy drug that can help stop cancer cells from dividing and growing. It may be used alone or in combination with other chemotherapy drugs for advanced or recurrent uterine cancer.
  • Carboplatin (Paraplatin): Carboplatin is a chemotherapy drug that can help kill cancer cells by damaging their DNA. It may be used alone or in combination with other chemotherapy drugs for advanced or recurrent uterine cancer.
  • Doxorubicin (Adriamycin): Doxorubicin is a chemotherapy drug that can help stop cancer cells from dividing and growing. It may be used alone or in combination with other chemotherapy drugs for advanced or recurrent uterine cancer.
  • Cisplatin (Platinol): Cisplatin is a chemotherapy drug that can help kill cancer cells by damaging their DNA. It may be used alone or in combination with other chemotherapy drugs for advanced or recurrent uterine cancer.

It is important to discuss the potential benefits and side effects of chemotherapy with a healthcare provider, as well as any potential drug interactions or allergies.

Targeted therapy medications may be used for the treatment of advanced or recurrent uterine cancer, especially in cases where the cancer cells have specific molecular targets that can be inhibited. Some targeted therapy medications used for uterine cancer treatment include:

  • Pembrolizumab (Keytruda): Pembrolizumab is a monoclonal antibody that can help the immune system attack cancer cells. It may be used alone or in combination with chemotherapy for advanced or recurrent uterine cancer that has certain molecular features.
  • Bevacizumab (Avastin): Bevacizumab is a monoclonal antibody that can help stop the growth of blood vessels that supply nutrients to cancer cells. It may be used in combination with chemotherapy for advanced or recurrent uterine cancer.
  • Everolimus (Afinitor): Everolimus is a medication that can help stop cancer cells from dividing and growing by targeting specific cellular pathways. It may be used in combination with hormonal therapy for advanced or recurrent uterine cancer.
  • Trastuzumab (Herceptin): Trastuzumab is a monoclonal antibody that can help stop the growth of cancer cells that overexpress the HER2 protein. It may be used in combination with chemotherapy for advanced or recurrent uterine cancer.

It is important to note that targeted therapy medications may have different side effects and risks compared to traditional chemotherapy, and may not be suitable for all patients. A healthcare provider can provide more information about the potential benefits and risks of targeted therapy for uterine cancer.

Hormone therapy medications may be used for the treatment of uterine cancer in cases where the cancer cells have specific hormone receptors that can be targeted. The two most common hormone therapy medications used for uterine cancer treatment are:

  • Progestins: Progestins are synthetic versions of the hormone progesterone, which can help stop the growth of uterine cancer cells. Progestin therapy may be used for women with early-stage or recurrent uterine cancer who have hormone receptor-positive tumors.
  • Aromatase inhibitors: Aromatase inhibitors can help reduce the amount of estrogen in the body by blocking the enzyme aromatase, which converts androgens into estrogens. Aromatase inhibitor therapy may be used for women with early-stage or recurrent uterine cancer who have hormone receptor-positive tumors.

It is important to note that hormone therapy medications may have different side effects and risks compared to traditional chemotherapy, and may not be suitable for all patients. A healthcare provider can provide more information about the potential benefits and risks of hormone therapy for uterine cancer.

The specific treatment approach for uterine cancer may vary depending on the stage and type of the cancer, as well as the individual patient. It is important to discuss treatment options and potential side effects with a healthcare provider to determine the best course of action.

Legitimate Healthcare Consultant and Facilitator In Delhi

If you have a question relating to anti-cancer medicines approved for treatment of Uteri Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Legitimate Healthcare Consultant and Facilitator

If you have a question relating to anti-cancer medicines approved for treatment of Pancreatic Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Query Form For Medications

Disclaimer

Please note that this article serves purely informational purposes, and Indian Pharma Network (“IPN, Delhi”) bears no responsibility for the opinions, advice, or information conveyed by the author, reviewer, or originator. It is important to note that this article should not be considered a substitute for medical advice, diagnosis, or treatment. Always seek guidance from your trusted physician or qualified healthcare professional to assess your medical situation. A qualified doctor has reviewed the aforementioned article, and IPN, Delhi disclaims any liability for any information or services rendered by third parties.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398